Who we are
At Kelso Pharma, we focus on innovative, niche and complex medicines that deliver benefits to patients and value to healthcare systems.
We enhance value for the healthcare system by providing medicines that improve the lives of patients in a cost-effective way and we are committed to behaving in an ethical manner in everything that we do.
Kelso Pharma continues to grow through a blend of company & product acquisitions, partnerships and organic growth, both in the UK and in Europe. We are focused on creating a positive, entrepreneurial working environment for our people, because a happy team creates value – for patients, the healthcare system and the business.
The company is backed by Apposite Capital LLP, a private equity firm specialising in investing in SME businesses in healthcare. The Kelso pharma team has extensive experience in growing and running a specialty pharma business across Europe.
Medicines
We focus on providing branded medicines that meet the needs of patients and are affordable for the healthcare system. Providing medicines that are easier to take improves patient compliance, delivering greater value to the healthcare system.
We encourage and focus on innovation, and we ensure that security of the supply of our medicines is a primary focus for the business, enabling our medicines to be made available to patients when and where they need them.
